Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cb9f654ff-w5vf4 Total loading time: 0 Render date: 2025-08-07T17:52:37.612Z Has data issue: false hasContentIssue false

3 - Depression: etiology and treatment

Published online by Cambridge University Press:  13 August 2009

Anthony Feinstein
Anthony Feinstein
Affiliation:
University of Toronto
Get access

Summary

In Ch. 2, data were presented defining the phenomenology of depression associated with MS. This is an essential precursor to studies that have explored the etiology of mood change. Indeed, some of the difficulties in determining which symptoms most accurately reflect mood change in MS patients may account, in part, for the inconsistencies in the neuroimaging data. It is, therefore, no coincidence that as symptom clarification proceeds in tandem with advances in neuroimaging brain–behavior correlations have become more robust.

This chapter will explore, first, putative etiological factors in relation to depression, namely genetics, brain imaging changes, endocrine dysfunction, immune system abnormalities and diverse psychosocial theories. Thereafter, a review of treatment modalities for depressed MS patients will be presented.

Etiology of depression in multiple sclerosis

The pathogenesis of the major depressive-like disorders frequently experienced by MS patients is unclear. Research has been undertaken to examine mood and MS using genetics, structural and functional neuroimaging, endocrine and immune system markers and social variables, and a mixed picture has emerged. The reasons for these partial successes and failures are reviewed and future research options suggested.

Genetics and depression

Evidence suggesting a genetic link between MS and unipolar depression is mixed. Based on the family history method, Joffe et al. (1987) did not find an excess of affective illness in the first-degree relatives of patients with MS, a finding in agreement with others (Minden et al., 1987; Schiffer et al., 1988).

Information

Type
Chapter
Information
The Clinical Neuropsychiatry of Multiple Sclerosis , pp. 46 - 65
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Aikens, JE, Fischer, JS, Namey, M, Rudick, RA. (1997) A replicated prospective investigation of life stress, coping and depressive symptoms in multiple sclerosis. Journal of Behavioral Medicine, 20, 433–445.CrossRefGoogle Scholar
Anzola, GP, Bevilacqua, L, Cappa, SF, et al. (1990) Neuropsychological assessment in patients with relapsing–remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging. Journal of Neurology, Neurosurgery and Psychiatry, 53, 142–145.CrossRefGoogle Scholar
Arnett, PA, Higginson, CI, Voss, WD, Randolph, JJ, Grandey, AA. (2002) Relationship between coping, cognitive dysfunction, and depression in multiple sclerosis. The Clinical Neuropsychologist, 16, 341–355.CrossRefGoogle Scholar
Bakshi, R, Miletich, RS, Kinkel, PR, Emmet, ML, Kinkel, WR. (1998) High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. Journal of Neuroimaging, 8, 228–234.CrossRefGoogle Scholar
Bakshi, R, Czarnecki, D, Shaikh, ZA, et al. (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport, 11, 1153–1158.CrossRefGoogle Scholar
Barak, Y, Ur, E, Achiron, A. (1999) Moclobemide treatment in multiple sclerosis patients with co-morbid depression: an open label safety trial. Journal of Neuropsychiatry and Clinical Neuroscience, 11, 271–273.CrossRefGoogle Scholar
Barnes, RH, Busse, EW, Dinken, H. (1954) Alleviation of emotional problems in multiple sclerosis by group psychotherapy. Group Psychotherapy, 6, 193–201.Google Scholar
Berg, D, Supprian, T, Thomae, J, et al. (2000) Lesion pattern in patients with multiple sclerosis and depression. Multiple Sclerosis, 6, 156–162.CrossRefGoogle Scholar
Blackburn, I. M., Eunson, K. M., Bishop, S. (1986) A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders, 10, 67–75.CrossRefGoogle Scholar
Bolding, H. (1960) Psychotherapeutic aspects in management of patients with multiple sclerosis. Diseases of the Nervous System, 21, 24–26.Google Scholar
Browning, WN. (1990) Exacerbation of symptoms of multiple sclerosis in a patient taking fluoxetine. American Journal of Psychiatry, 147, 1089.CrossRefGoogle Scholar
Carson, AJ, MacHale, S, Allen, K, et al. (2000) Depression after stroke and lesion location: a systematic review. Lancet, 356, 122–126.CrossRefGoogle Scholar
Crawford, JD, McIvor, GP. (1985) Group psychotherapy: benefits in multiple sclerosis. Archives of Physical Medical Rehabilitation, 66, 810–813.Google Scholar
Day, M, Day, E, Herrmann, R. (1953) Group therapy of patients with multiple sclerosis. Archives of Neurology and Psychiatry, 69, 193–196.CrossRefGoogle Scholar
Derubeis, RJ, Hollon, SD, Amsterdam, JD, et al. (2005) Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62, 409–416.CrossRefGoogle Scholar
Eastwood, MR, Rifat, SL, Nobbs, H, Ruderman, J. (1989) Mood disorder following CVA. British Journal of Psychiatry, 154, 195–200.CrossRefGoogle Scholar
Fassbender, K, Schmidt, R, Mößner, R, et al. (1998) Mood disorders and dysfunction of the hypothalamic–pituitary–adrenal axis in multiple sclerosis. Archives of Neurology, 55, 66–72.CrossRefGoogle Scholar
Feinstein, A. (1995) Multiple sclerosis and depression: an etiological conundrum. Canadian Journal of Psychiatry, 40, 573–576.CrossRefGoogle Scholar
Feinstein, A. (2004). The neuropsychiatry of multiple sclerosis. Canadian Journal of Psychiatry, 49, 157–163.CrossRefGoogle Scholar
Feinstein, A, Youl, B, Ron, MA. (1992a) Acute optic neuritis: a cognitive and magnetic resonance imaging study. Brain, 115, 1403–1415.Google Scholar
Feinstein, A, Kartsounis, L, Miller, B, Youl, B, Ron, MA. (1992b) Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric and MRI follow-up study. Journal of Neurology, Neurosurgery and Psychiatry, 55, 869–876.Google Scholar
Feinstein, A, Roy, P, Lobaugh, N, Feinstein, KJ, O'Connor, P. (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology, 62, 586–590.CrossRefGoogle Scholar
Flax, JW, Gray, J, Herbert, J. (1991) Effects of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry, 148, 1603.CrossRefGoogle Scholar
Foley, FW, Bedell, JR, LaRocca, NG, Scheinberg, LC, Reznikoff, M. (1987) Efficacy of stress-inoculation training in coping with multiple sclerosis. Journal of Consulting and Clinical Psychology, 55, 919–922.CrossRefGoogle Scholar
Foley, FW, Traugott, U, LaRocca, NG, et al. (1992) A prospective study of depression and immune dysregulation in multiple sclerosis. Archives of Neurology, 49, 238–244.CrossRefGoogle Scholar
Gallineck, A, Kalinowsky, LB. (1958) Psychiatric aspects of multiple sclerosis. Diseases of the Nervous System, 19, 77–80.Google Scholar
George, MS, Kellner, CH, Bernstein, H, Goust, JM. (1994) A magnetic resonance imaging investigation into mood disorders in multiple sclerosis. Journal of Nervous and Mental Disease, 182, 410–412.Google Scholar
Gershon, ES, Hamovit, J, Guroff, JJ, et al. (1982) A family study of schizoaffective, bipolar 1, bipolar 11, unipolar, and normal control probands. Archives of General Psychiatry, 39, 1157–1167.CrossRefGoogle Scholar
Goldman Consensus Group. (2005). The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 11, 328–337.CrossRef
Honer, WG, Hurwitz, T, Li, DKB, Palmer, M, Paty, DW. (1987) Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Archives of Neurology, 44, 187–190.CrossRefGoogle Scholar
Huber, SJ, Paulsen, GW, Shuttleworth, EC, et al. (1987) Magnetic resonance imaging correlates of dementia in multiple sclerosis. Archives of Neurology, 44, 732–736.CrossRefGoogle Scholar
Hussain IF, Fowler CJ. (2000) The cause and management of bladder, sexual and bowel symptoms. In The Principles and Treatment of Multiple Sclerosis, Ed. Hawkins, CP, Wolinsky, JS. Oxford: Butterworth Heinemann, pp. 258–281.
Jean, VM, Beatty, WW, Paul, RH, Mullins, L. (1997) Coping with general and disease related stressors by patients with multiple sclerosis: relationships to psychological distress. Multiple Sclerosis, 3, 191–196.CrossRefGoogle Scholar
Joffe, RT, Lippert, GP, Gray, TA, Sawa, G, Horvath, Z. (1987) Personal and family history of affective disorder, Journal of Affective Disorders, 12, 63–65.Google Scholar
Krystal, AD, Coffey, CE. (1997) Neuropsychiatric considerations in the use of electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 283–292.CrossRefGoogle Scholar
Larcombe, NA, Wilson, PH. (1984) An evaluation of cognitive–behaviour therapy for depression in patients with multiple sclerosis. British Journal of Psychiatry, 145, 366–371.CrossRefGoogle Scholar
Linde, K, Ramirez, G, Mulrow, CD, et al. (1996) St. John's wort for depression: an overview and meta-analysis of randomised clinical trials. British Medical Journal, 313, 253–258.CrossRefGoogle Scholar
Lobentanz, IS, Asenbaum, S, Vass, K, et al. (2004) Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurologica Scandinavica, 110, 6–13.CrossRefGoogle Scholar
Logsdail, SJ, Callanan, MM, Ron, MA. (1988) Psychiatric morbidity in patients with clinically isolated lesions of the type seen in multiple sclerosis. Psychological Medicine, 18, 355–364.CrossRefGoogle Scholar
Lynch, SG. Kroencke, DC, Denney, DR. (2001) The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Multiple Sclerosis, 7, 411–416.CrossRefGoogle Scholar
Mattingley, G, Baker, K, Zorumski, CF, Figiel, GS. (1992) Multiple sclerosis and ECT: possible value of gadolinium enhanced magnetic resonance scans for identifying high risk patients. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 145–151.CrossRefGoogle Scholar
Mayberg HS. (1993) Neuroimaging studies of depression in neurological disease. In Depression in Neurological Disease, ed. Starkstein, SE, Robinson, RG, pp. 186–216. Baltimore, MD: Johns Hopkins University Press.
Mayberg, HS (1994) Frontal lobe dysfunction in secondary depression. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 428–442.CrossRefGoogle Scholar
Mayberg, HS, Starkstein, SE, Sadzot, B, et al. (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Annals of Neurology, 28, 57–64.CrossRefGoogle Scholar
Mayberg, HS, Starkstein, SE, Peyser, CE, et al. (1992) Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology, 42, 1791–1797.Google Scholar
Maybury, CP, Brewin, CR. (1984) Social relationships, knowledge and adjustment to multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 47, 372–376.CrossRefGoogle Scholar
Michelson, D, Stone, L, Galliven, E, et al. (1994) Multiple sclerosis is associated with alterations in hypothalamic–pituitary–adrenal axis function. Journal of Clinical Endocrinology and Metabolism, 79, 848–853.Google Scholar
Minden, SL. (1992) Psychotherapy for people with multiple sclerosis. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 198–213.CrossRefGoogle Scholar
Minden, SL, Orav, J, Reich, P. (1987) Depression in multiple sclerosis. General Hospital Psychiatry, 9, 426–434.CrossRefGoogle Scholar
Mohr, DC, Goodkin, D. (1999) Treatment of depression in multiple sclerosis. Review and meta-analysis. Clinical Psychology: Science and Practice, 6, 1–9.Google Scholar
Mohr, DC, Goodkin, , Gatto, N, Wende, J. (1997) Depression, coping and level of neurological impairment in multiple sclerosis. Multiple Sclerosis, 3, 254–258.CrossRefGoogle Scholar
Mohr, DC, Likosky, W, Bertagnolli, A, et al. (2000) Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. Consulting and Clinical Psychology, 68, 356–361.CrossRefGoogle Scholar
Mohr, DC, Goodkin, , Islar, J, Hauser, SL, Genain, CP. (2001a) Treatment of depression is associated with suppression of nonspecific and antigen specific TH1 response in multiple sclerosis. Archives of Neurology, 58, 1081–1086.Google Scholar
Mohr, DC, Boudewyn, AC, Goodkin, D, Bostrom, A, Epstein, L. (2001b) Comparative outcomes for individual cognitive–behavior therapy, supportive–expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 69, 942–949.Google Scholar
Mohr, DC, Epstein, L, Luks, TL, et al. (2003) Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 71, 1017–1024.CrossRefGoogle Scholar
Mohr, DC, Hart, SL, Fonareva, I, Tasch, ES. (2006) Treatment of depression for patients with multiple sclerosis in neurology clinics. Multiple Sclerosis, 12, 204–208.CrossRefGoogle Scholar
Pakenham, KI. (1999) Adjustment to multiple sclerosis: application of a stress coping model. Health Psychology, 18, 383–392.CrossRefGoogle Scholar
Pakenham, KI, Stewart, CA, Rogers, A. (1997) The role of coping in adjustment to multiple sclerosis: related adaptive demands. Psychology, Health and Medicine, 2, 197–211.Google Scholar
Patten, SB, Metz, LM. (2002) Hopelessness ratings in relapsing–remitting and secondary progressive multiple sclerosis. International Journal of Psychiatry in Medicine, 32, 155–165.Google Scholar
Patten, SB, Metz, LM, Reimer, MA. (2000) Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis, 6, 115–120.CrossRefGoogle Scholar
Pavlou, M, Johnson, P, Davis, FA, Lefebre, K. (1979) Program of psychologic service delivery in multiple sclerosis centre. Professional Psychology, 10, 503–510.CrossRefGoogle Scholar
Pujol, J, Bello, J, Deus, J, Marti-Vilalta, JL, Capdevila, A. (1997) Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology, 49, 1105–1110.CrossRefGoogle Scholar
Pujol, J, Bello, J, Deus, J, et al. (2000) Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region. Psychiatry Research: Neuroimaging, 99, 151–159.CrossRefGoogle Scholar
Rabins, PV, Brooks, BR, O'Donnell, P, et al. (1986) Structural brain correlates of emotional disorder in multiple sclerosis. Brain, 109, 585–597.CrossRefGoogle Scholar
Rao, SM, Leo, GJ, Haughton, VM, St. Aubin-Faubert, P, Bernardin, L. (1989) Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology, 39, 161–166.CrossRefGoogle Scholar
Rao, SM, Leo, HJ, Bernardin, L, Unverzagt, F. (1991) Cognitive dysfunction in multiple sclerosis. Neurology, 41, 685–691.CrossRefGoogle Scholar
Reder, AT, Lowy, MT, Meltzer, HY, Antel, JP. (1987) Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy. Neurology, 37, 849–853.CrossRefGoogle Scholar
Reischies, FM, Baum, K, Brau, H, Hedde, JP, Schwindt, G. (1988) Cerebral magnetic resonance imaging findings in multiple sclerosis. Relation to disturbance of affect, drive and cognition. Archives of Neurology, 45, 1114–1116.CrossRefGoogle Scholar
Robinson, RG, Kubos, KL, Starr, LB, Rao, K, Price, TR. (1983) Mood disorders in stroke patients: relationship to lesion location. Comprehensive Psychiatry, 24, 555–556.Google Scholar
Ron, MA, Logsdail, SJ. (1989) Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychological Medicine, 19, 887–895.CrossRefGoogle Scholar
Rush, AJ, Beck, A, Kovacs, M, Hollon, SD. (1977) Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed out-patients. Cognitive Therapy and Research, 1, 17–37.CrossRefGoogle Scholar
Sabatini, U, Pozzilli, C, Pantano, P, et al. (1996) Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biological Psychiatry, 39, 970–975.CrossRefGoogle Scholar
Schiffer, RB. (1987) The spectrum of depression in multiple sclerosis. An approach for clinical management. Archives of Neurology, 44, 596–599.CrossRefGoogle Scholar
Schiffer, RB, Wineman, NM. (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. American Journal of Psychiatry, 147, 1493–1497.CrossRefGoogle Scholar
Schiffer, RB, Caine, ED, Bamford, KA, Levy, S. (1983) Depressive episodes in patients with multiple sclerosis. American Journal of Psychiatry, 140, 1498–1500.CrossRefGoogle Scholar
Schiffer, RB, Weitkamp, LR, Wineman, NM, Guttormsen, S. (1988) Multiple sclerosis and affective disorder: family history, sex and HLA-DR antigens. Archives of Neurology, 45, 1345–1348.CrossRefGoogle Scholar
Scott, TF, Nussbaum, P, McConnell, H, Brill, P. (1995) Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurological Research, 17, 421–422.CrossRefGoogle Scholar
Scott, TF, Allen, D, Price, TRP, McConnell, H, Lang, D. (1996) Characterization of major depression symptoms in multiple sclerosis. Journal of Neuropsychiatry and Clinical Neurosciences, 8, 318–323.CrossRefGoogle Scholar
Shafey, H. (1992) The effect of fluoxetine in depression associated with multiple sclerosis. Canadian Journal of Psychiatry, 37, 147–148.CrossRefGoogle Scholar
Shnek, ZM, Foley, FW, LaRocca, NG, et al. (1997) Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Annals of Behavioral Medicine, 19, 287–94.CrossRefGoogle Scholar
Singh, A, Herrmann, N, Black, SE. (1998) The importance of lesion location in poststroke depression: a critical review. Canadian Journal of Psychiatry, 43, 921–927.CrossRefGoogle Scholar
Spielberg, N. (1980) Support group improves quality of life. Rehabilitation, Nurses Journal, 5, 9–11.CrossRefGoogle Scholar
Starkstein, SE, Robinson, RG. (1989) Affective disorders and cerebral vascular disease. British Journal of Psychiatry, 154, 170–182.CrossRefGoogle Scholar
Werf, SP, Evers, A, Jongen, PJH, Bleijenberg, G. (2003) The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis. Multiple Sclerosis, 3, 89–94.Google Scholar
Voss, WD, Arnett, PA, Higginson, CI, et al. (2002) Contributing factors to depressed mood in multiple sclerosis. Archives of Clinical Neuropsychology, 17, 103–115.CrossRefGoogle Scholar
Wei, T, Lightman, SL. (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain, 120, 1067–1076.CrossRefGoogle Scholar
Zorzon, M, Masi, R, Nasuelli, D, et al. (2001) Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. Journal of Neurology, 248, 416–421.CrossRefGoogle Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×